Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Gains from Sales and Divestitures (2016 - 2025)

Historic Gains from Sales and Divestitures for Jaguar Health (JAGX) over the last 3 years, with Q3 2025 value amounting to $1292.0.

  • Jaguar Health's Gains from Sales and Divestitures changed N/A to $1292.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1292.0, marking a year-over-year change of. This contributed to the annual value of $20789.0 for FY2017, which is 2513.32% down from last year.
  • Per Jaguar Health's latest filing, its Gains from Sales and Divestitures stood at $1292.0 for Q3 2025.
  • Jaguar Health's 5-year Gains from Sales and Divestitures high stood at $1292.0 for Q3 2025, and its period low was $4.0 during Q2 2025.